Infinity academy |4th stage

Clinical pharmacy 2026

بالجيب امسكيو عن الروماتيد

🚨 ممنوعات مطلقة (Absolute Contraindications): يُمنع منعاً باتاً دمج دواءين بيولوجيين معاً، أو دمج دواء بيولوجي مع مثبط JAK، بسبب خطر تثبيط المناعة الشديد. يُمنع إعطاء اللقاحات الحية (Live vaccines) للمرضى. قبل البدء: يجب فحص المريض ضد السل الكامن (latent tuberculosis) والتهاب الكبد B (hepatitis B

A 62-year-old male (Weight: 115 kg) with a 15-year history of Type 2 Diabetes Mellitus (T2DM) and Hypertension presents for a comprehensive review. He has a history of Myocardial Infarction (MI) two years ago and was recently diagnosed with Heart Failure (HFrEF) and Chronic Kidney Disease (CKD).  Current Clinical Presentation: 1. Respiratory: Persistent, non-productive dry cough for 3 weeks.  2. Neurological: Significant burning pain and numbness in both feet, worsening at night (Peripheral Neuropathy).  3. Gastrointestinal: Recurring episodes of nocturnal diarrhea.  4. Autonomic: Frequent dizziness upon standing (Orthostatic hypotension).  5. Emergency: One recent episode of severe confusion and tremors (Level 3 Hypoglycemia) requiring external assistance.  Current Medications: • Metformin 1000 mg BID.  • Lisinopril 40 mg Daily.  • Glimepiride 4 mg Daily.  • Pioglitazone 30 mg Daily.  • Simvastatin 40 mg Daily.  Clinical Findings & Labs: • BP: 158/96 mmHg.  • A1C: 9.4%.  • eGFR: 31 mL/min/1.73m².  • Potassium (K^+): 5.6 mEq/L (Hyperkalemia).  • UACR: 480 mg/g (Significant Albuminuria).  Question: Based on the provided pharmacological guidelines, which of the following integrated management plans is the most appropriate next step for this patient? A) Discontinue Lisinopril and initiate Spironolactone; switch Glimepiride to Empagliflozin; add Pregabalin for foot pain; and treat diarrhea with a 10-day course of Doxycycline. B) Switch Lisinopril to Valsartan; discontinue Pioglitazone and Glimepiride; initiate Basal Insulin and Dapagliflozin; add Duloxetine for neuropathy; and prescribe a Glucagon emergency kit. C) Maintain Lisinopril but add Amlodipine for blood pressure; switch Metformin to Sitagliptin; add Amitriptyline for neuropathy; and use the “Rule of 15” with complex carbohydrates to manage hypoglycemia. D) Switch Lisinopril to Losartan; discontinue Pioglitazone; initiate Semaglutide (GLP-1 RA) and Empagliflozin; add Midodrine for orthostatic hypotension; and treat diarrhea with Metronidazole. E) Switch Lisinopril to Valsartan; discontinue Glimepiride; add Aliskiren for renal protection; add Gabapentin for neuropathy; and increase Simvastatin to 80 mg for high-intensity therapy.

يابطل مضبط السكري يحله🫣؟ @infinity_4r

A) Discontinue Metformin and Pioglitazone. Initiate Insulin Glargine 10 units at bedtime and increase Glyburide to 20 mg daily. Continue Simvastatin 20 mg. B) Discontinue Pioglitazone and Glyburide. Initiate Empagliflozin 10 mg daily. Continue Metformin. Change Simvastatin 20 mg to Atorvastatin 80 mg daily. C) Continue all current antidiabetic medications. Initiate Dulaglutide 0.75 mg weekly to induce weight loss. Increase Lisinopril to 40 mg daily. D) Discontinue Glyburide. Initiate Sitagliptin 100 mg daily. Continue Pioglitazone and Metformin. Add Fenofibrate to provide cardiovascular protection. E) Discontinue Metformin. Increase Pioglitazone to 45 mg daily to overcome insulin resistance. Initiate Dapagliflozin 10 mg daily.

A 68-year-old male presents to the clinic for a routine follow-up of his Type 2 Diabetes Mellitus. He reports increasing shortness of breath upon exertion over the past three weeks, an unexpected weight gain of 4 kg, and noticeable bilateral lower extremity edema. Furthermore, he mentions experiencing episodes of sweating, tremors, and severe hunger occurring predominantly in the late mornings before lunch, which resolve after drinking fruit juice. Past Medical History (PMH): Type 2 Diabetes Mellitus (diagnosed 12 years ago) Heart Failure with reduced Ejection Fraction (HFrEF; LVEF 35%, NYHA Class III) Established Atherosclerotic Cardiovascular Disease (ASCVD) - Myocardial Infarction 3 years ago Hypertension Diabetic Nephropathy (with macroalbuminuria) Peripheral Neuropathy Current Medications: Metformin 1000 mg orally twice daily Pioglitazone 30 mg orally once daily Glyburide 10 mg orally once daily Lisinopril 20 mg orally once daily Carvedilol 12.5 mg orally twice daily Simvastatin 20 mg orally once daily Aspirin 81 mg orally once daily Vitals & Physical Examination: Blood Pressure: 138/86 mm Hg Heart Rate: 72 bpm Body Mass Index (BMI): 32 kg/m² (Obese) Physical Exam: 2+ pitting edema in both lower extremities; lung auscultation reveals mild bibasilar crackles. Laboratory Results: A1C: 8.9% (Target individualized: < 7.5%) Fasting Plasma Glucose (FPG): 165 mg/dL Serum Creatinine (SCr): 1.5 mg/dL Estimated Glomerular Filtration Rate (eGFR): 48 mL/min/1.73 m² Urine Albumin-to-Creatinine Ratio (UACR): 450 mg/g (Macroalbuminuria) Question: Based on the patient's clinical presentation, laboratory findings, and current guidelines, which of the following is the MOST appropriate pharmacological intervention?

ترى 🔥

محاضرة تجريبية لشرح موضوع Aminoglycoside بأسلوب مبسّط وواضح حتى تاخذ فكرة عن طريقة الشرح داخل الكورس ✨ 📖 باقي محاضرات المادة مشروحة بالكامل داخل الكورس 🎯 شرح واضح + تبسيط للمعلومات المهمة 📌 للاستفسار والتسجيل: 📩 @infinity_4r

� فيديو مجاني — شرح Tetracycline طلاب المرحلة الرابعة ✨ تم نشر فيديو مجاني لشرح موضوع Tetracycline بشكل مبسّط وواضح حسب المنهج الوزاري 📚💊 📌 ملاحظة مهمة: باقي فيديوهات المادة مشروحة بالكامل داخل الكورس ومرتبة حسب منهج جامعة النور خطوة بخطوة لضمان الفهم السهل والمراجعة السريعة. 📩 للاشتراك في الكورس: يكون عبر حساب الأكاديمية: @infinity_4r لا تضيع الفرصة وابدأ من الآن 🚀

تم إكمال جزء كبير من جابتر antibacterial لمادة العضوية الصيدلانية المرحلة الرابعة للإستفسار @infinity_4r